You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 21, 2024

SYMPAZAN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Sympazan, and what generic alternatives are available?

Sympazan is a drug marketed by Otter Pharms and is included in one NDA. There are three patents protecting this drug.

This drug has one hundred and sixty-eight patent family members in nineteen countries.

The generic ingredient in SYMPAZAN is clobazam. There are ten drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the clobazam profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Sympazan

A generic version of SYMPAZAN was approved as clobazam by AMNEAL on October 22nd, 2018.

  Try a Trial

US Patents and Regulatory Information for SYMPAZAN

SYMPAZAN is protected by three US patents.

Patents protecting SYMPAZAN


Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: METHOD OF TREATING SEIZURES

Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Otter Pharms SYMPAZAN clobazam FILM;ORAL 210833-001 Nov 1, 2018 RX Yes No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Otter Pharms SYMPAZAN clobazam FILM;ORAL 210833-003 Nov 1, 2018 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Otter Pharms SYMPAZAN clobazam FILM;ORAL 210833-002 Nov 1, 2018 RX Yes No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for SYMPAZAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Otter Pharms SYMPAZAN clobazam FILM;ORAL 210833-002 Nov 1, 2018 ⤷  Try a Trial ⤷  Try a Trial
Otter Pharms SYMPAZAN clobazam FILM;ORAL 210833-001 Nov 1, 2018 ⤷  Try a Trial ⤷  Try a Trial
Otter Pharms SYMPAZAN clobazam FILM;ORAL 210833-003 Nov 1, 2018 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for SYMPAZAN

See the table below for patents covering SYMPAZAN around the world.

Country Patent Number Title Estimated Expiration
Mexico PA05012815 PELICULAS BASADAS EN OXIDO DE POLIETILENO Y SISTEMAS PARA SUMINISTRO DE FÁRMACOS ELABORADOS CON ELLAS. (POLYETHYLENE OXIDE-BASED FILMS AND DRUG DELIVERY SYSTEMS MADE THEREFROM.) ⤷  Try a Trial
South Korea 20160029730 설하 및 구강 필름 조성물 (SUBLINGUAL AND BUCCAL FILM COMPOSITIONS) ⤷  Try a Trial
Japan 2009518405 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing